Announcement • Jun 24
Nanalysis Scientific Corp. Announces Appointment of Heather Kury as CFO Nanalysis Scientific Corp. had appointed Heather Kury, CPA, CA, as Chief Financial Officer following her service as interim CFO. Ms Kury has more than twenty years of experience helping both public and private companies improve corporate strategy and operational performance. Prior to joining Nanalysis, she held senior finance and leadership roles in the oil and gas and information technology sectors. Ms Kury is a member of the Institute of Chartered Professional Accountants of Alberta and holds a Bachelor of Arts from the University of Winnipeg. Announcement • May 14
Nanalysis Scientific Corp. to Report Q1, 2026 Results on May 20, 2026 Nanalysis Scientific Corp. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 20, 2026 Announcement • Apr 02
Nanalysis Scientific Corp. to Report Q4, 2025 Results on Apr 08, 2026 Nanalysis Scientific Corp. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Apr 08, 2026 Announcement • Jan 27
Nanalysis Scientific Corp. announced that it has received CAD 3.400737 million in funding On January 26, 2026, the Nanalysis Scientific Corp closed the transaction by issuing 6,145,300 units at an issue price of CAD 0.15 for the proceeds of CAD 921,795 under second and final tranche. In connection with the second tranche of the Offering, the Company paid an aggregate of CAD 2,000 in cash commission finder's fees to Leede Financial Inc Announcement • Dec 08
Nanalysis Scientific Corp. announced that it expects to receive CAD 2.5 million in funding Nanalysis Scientific Corp. announced a non-brokered private placement of up to 16,666,667 units at a price of CAD 0.15 per unit for aggregate gross proceeds of up to CAD 2,500,000.05 on December 8, 2025. Each unit will consist of one common share and one-half of one common share purchase warrant. Each warrant will entitle the holder to acquire one share at an exercise price of CAD 0.20 per share at any time up to on or before the date that is two years from the closing date of the offering. Completion of the offering is subject to the acceptance of the TSX Venture Exchange and other customary closing conditions. The offering may close in one or more tranches, with the initial closing anticipated to occur on or about December 15, 2025. The units, and all securities underlying the units, will be subject to a statutory hold period of four months and one day from their date of issue in accordance with applicable securities laws. Announcement • Nov 18
Nanalysis Scientific Corp. to Report Q3, 2025 Results on Nov 24, 2025 Nanalysis Scientific Corp. announced that they will report Q3, 2025 results After-Market on Nov 24, 2025 Announcement • Nov 14
Nanalysis Announces CFO Changes, Effective December 5, 2025 Nanalysis Scientific Corp. announced that Randall McRae has resigned as Chief Financial Officer of the Company effective December 5, 2025. Mr. McRae will continue to serve as the Chief Financial Officer until his departure, and will remain available to the company on an advisory basis going forward. Heather Kury, Corporate Controller of the Company, will be appointed as Interim Chief Financial Officer while the board of directors of the Company searches for a permanent successor. Heather Kury, CPA, CA has over twenty years of experience helping both public and private companies, improve their corporate strategy and operational excellence. Prior to Nanalysis, Ms. Kury held senior roles within companies both locally and internationally in the oil and gas and information technology sectors. Ms. Kury is enthusiastic about this opportunity and looks forward to continuing to work with the Nanalysis team as the Company continues to grow and develop. Heather is a member of the Institute of Chartered Professional Accountants of Alberta and holds a Bachelor of Arts (Accounting and History) from the University of Winnipeg. Announcement • Aug 22
Nanalysis Scientific Corp. to Report Q2, 2025 Results on Aug 28, 2025 Nanalysis Scientific Corp. announced that they will report Q2, 2025 results on Aug 28, 2025 Announcement • Jul 16
Nanalysis Scientific Corp., Annual General Meeting, Sep 22, 2025 Nanalysis Scientific Corp., Annual General Meeting, Sep 22, 2025. Announcement • Jun 06
Nanalysis Scientific Corp. announced that it has received CAD 2 million in funding Nanalysis Scientific Corp. announced that it has issue unsecured promissory notes for aggregate gross proceeds of CAD 2,000,000 on June 6, 2025. The transaction included participation from Pathfinder Asset Management Limited of CAD 1,000,000 million. The company issued notes at simple interest rate of 12% per annum and notes will mature two years from the date of issuance. The Notes will be issued to arm's length third-party. the transaction is subject to approval from regulatory authorities. The Notes will mature two years from the date of issuance. The Company will pay a finders fee of up to 5% of the gross proceeds of the Notes in cash. Announcement • May 30
Nanalysis Scientific Corp. Provides Sales Guidance for the Full Year 2025 Nanalysis Scientific Corp. provided sales guidance for the full year 2025. As 2025 continues, the company have maintained a strong sales funnel into the second quarter and full year 2025. While the Company is optimistic that sales for the full year will not be impacted by tariffs and economic uncertainty, it is possible that product sales growth in 2025 will face some headwinds. Announcement • May 15
Nanalysis Scientific Corp. to Report Q1, 2025 Results on May 28, 2025 Nanalysis Scientific Corp. announced that they will report Q1, 2025 results on May 28, 2025 Announcement • Apr 26
Nanalysis Scientific Corp. Announces Resignation of René Lenggenhager from the Board of Directors Nanalysis Scientific Corp. announced that René Lenggenhager has resigned from the Board of Directors. The Company thanks him for his service and wishes him well. Announcement • Apr 17
Nanalysis Scientific Corp. to Report Q4, 2024 Results on Apr 24, 2025 Nanalysis Scientific Corp. announced that they will report Q4, 2024 results at 4:00 PM, US Eastern Standard Time on Apr 24, 2025 Announcement • Nov 07
Nanalysis Scientific Corp. to Report Q3, 2024 Results on Nov 21, 2024 Nanalysis Scientific Corp. announced that they will report Q3, 2024 results on Nov 21, 2024 Announcement • Aug 14
Nanalysis Scientific Corp. to Report Q2, 2024 Results on Aug 28, 2024 Nanalysis Scientific Corp. announced that they will report Q2, 2024 results on Aug 28, 2024 Announcement • May 23
Nanalysis Scientific Corp. to Report Q1, 2024 Results on May 29, 2024 Nanalysis Scientific Corp. announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on May 29, 2024 Announcement • Apr 28
Nanalysis Scientific Corp., Annual General Meeting, Jun 26, 2024 Nanalysis Scientific Corp., Annual General Meeting, Jun 26, 2024. Announcement • Apr 12
Nanalysis Scientific Corp. to Report Q4, 2023 Results on Apr 25, 2024 Nanalysis Scientific Corp. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Apr 25, 2024 Announcement • Apr 10
Nanalysis Scientific Corp. Announces Resignation of Kham Lin as A Director Nanalysis Scientific Corp. announced that Kham Lin has resigned as a director of the Company effective April 9, 2024, and the Board of Directors has accepted his resignation. The Company would like to thank Mr. Lin for his contributions throughout his tenure as director of the Company. Announcement • Apr 05
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances Nanalysis Scientific Corp. announced that its subsidiary Nanalysis Corp. is receiving advisory services and up to $1.45 million in non-repayable, non-dilutive funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), to develop Artificial Intelligence based software tools to detect illicit substances on top of the company's portable Nuclear Magnetic Resonance (NMR) spectrometers. In the global fight against substance abuse, federal, state, provincial, county and municipal governments around the world are tasked with characterizing increasing volumes of seized contraband. This characterization requires an array of different analytical techniques and is carried out by skilled forensic scientists in thousands of laboratories worldwide. In many cases these laboratories face significant sample backlog due to volume and may have difficulties in identifying new designer drugs. This project, scheduled for three years, will focus on using quantum mechanical modelling and AI tools to perform analysis of magnetic resonance results generated by Nanalysis benchtop instruments. These tools will not only identify known illicit drugs but will also identify unknown drugs that are derivatives of known illicit substances also referred to as designer drugs or new psychoactive substances (NPS). The non-destructive nature of NMR spectroscopy and the fact that unlike traditional forensic testing methods, it is non-targeted, uniquely positions it to help identify these drugs. The company is developing this application in the context of its quantitative NMR platform technology, which has other applications as well, beyond illicit drug detection. Announcement • Mar 07
Nanalysis Scientific Corp. announced that it expects to receive CAD 1 million in funding Nanalysis Scientific Corp. announced brokered best efforts private placement to issue 2,222,222 units at a price CAD 0.45 for a gross proceeds CAD 999,999.9 on March 6, 2024. Each Unit will consist of one common share of the Company and one half of one common share purchase warrant of the Company. Each Warrant will be exercisable at CAD 0.65 for a period of 24 months following the closing date of the Offering. The transaction is expected to close on March 20, 2024, or such other date as may be agreed upon by the Company. The transaction is subject to the receipt of all necessary approvals, including the approval of the TSX Venture Exchange and regulatory approval. Announcement • Feb 07
Nanalysis Scientific Corp. Provides Earnings Guidance for the Fourth Quarter 2023 Nanalysis Scientific Corp. provided earnings guidance for the fourth quarter 2023. The company able to achieve fourth quarter unaudited revenues of between $9.3 million and $9.8 million, constituting a new record quarter for Nanalysis. Announcement • Nov 17
Nanalysis Scientific Corp. to Report Q3, 2023 Results on Nov 29, 2023 Nanalysis Scientific Corp. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 29, 2023 Announcement • Aug 16
Nanalysis Scientific Corp. to Report Q2, 2023 Results on Aug 24, 2023 Nanalysis Scientific Corp. announced that they will report Q2, 2023 results on Aug 24, 2023 Announcement • May 19
Nanalysis Scientific Corp. to Report Q1, 2023 Results on May 25, 2023 Nanalysis Scientific Corp. announced that they will report Q1, 2023 results on May 25, 2023 Announcement • May 04
Nanalysis Scientific Corp. announced that it has received CAD 4.1287 million in funding On May 3, 2023, Nanalysis Scientific Corp. closed the transaction. The company issued 3,142,500? units at a price of CAD 0.60 per unit for the gross proceeds of CAD 1,885,50?0 in its final tranche for the aggregate gross proceeds of CAD 4,128,700. 
